The Biotech Deal That Became a Leadership Crisis | Philip Borden (3/4)
Episode Ep 274 30 min 2s

The Biotech Deal That Became a Leadership Crisis | Philip Borden (3/4)

Philip Borden describes leaving Frazier Healthcare Partners for Harvard Business School, where the case method broadened his perspective beyond healthcare and investing. He explains why he returned to healthcare investing after graduation.

Community discussion